首页> 外文会议>Clinical Histocompatibility Workshop. >IS THERE A ROLE FOR ANTI-HLA ANTIBODIES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCT)?
【24h】

IS THERE A ROLE FOR ANTI-HLA ANTIBODIES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCT)?

机译:造血干细胞移植(HCT)中的抗HLA抗体是否存在作用?

获取原文

摘要

Donor specific anti-HLA antibodies may be mediators of graft rejection in solid organ transplantation but little is known of their role in hematopoietic stem cell transplantation (HCT). In an ongoing study, we are evaluating recipients of matched unrelated donor HCT (10/10 allele match) for pre and post anti-HLA Class I and/or Class II antibodies in order to determine if the presence of antibody has an impact on the outcome unrelated hematopoietic stem cell transplantation. A total of 139 patients were screened for HLA- specific antibodies using LABScreen Mix (LMAS, One Lambda) and the antibodies identified with the single antigen bead assays (Class I and Class II, One Lambda) with a cut-off of 1000 mean fluorescence units (MFI). The patient sera were screened 30 days prior to transplantation, and at 30, 60, and 90 days post transplantation out to a maximum of 258 days.
机译:供体特异性抗HLA抗体可以是固体器官移植中移植物排斥的介质,但毫无少地均以造血干细胞移植(HCT)中的作用。在持续的研究中,我们正在评估匹配的不相关的供体HCT(10/10等位基因匹配)的接受者,用于预先和后抗HLA类I和/或II类抗体,以确定抗体是否存在对该抗体的影响结果不相关的造血干细胞移植。使用Labscreen Mix(LMA,一个λ)和用单一抗原珠测定(I类和II类,一λ)鉴定的抗体的HLA特异性抗体筛选了139名患者,其中截止了1000个平均荧光单位(MFI)。在移植前30天筛选患者血清,将移植后30,60和90天筛选至最多258天。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号